Did Trump Get Special Access to Retatrutide? (opens in new tab)

Covers 2 stories including STAT+: Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?

While members of his cabinet stuff sauerkraut down their wives’ handbags to maintain diets, speculation is suddenly mounting over whether President Donald Trump may have received early access to retatrutide, the potent experimental weight-loss drug from Eli Lilly and eagerly anticipated by millions. The questions come amid a new report in STAT News pointing to a […]

Read the original article